Identification of melanoma metastases by tyrosinase-reverse transcription-polymerase chain reaction of fine needle aspirates.

[1]  M. Ross,et al.  Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Hauschild,et al.  Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  V. Sondak,et al.  The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. , 1997, Journal of the American Academy of Dermatology.

[4]  J. G. van den Tweel,et al.  Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. , 1996, The American journal of pathology.

[5]  D. Colomer,et al.  Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W. Sterry,et al.  Identification of lymph node metastases by use of polymerase chain reaction (PCR) in melanoma patients. , 1996, European journal of cancer.

[7]  L. Xerri,et al.  Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. , 1995, Archives of dermatology.

[8]  D. Reintgen,et al.  Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma , 1994, Annals of surgery.

[9]  W. Sterry,et al.  Identification of lymph node metastases by use of PCR in melanoma patients , 1994 .

[10]  C. Scheibenbogen,et al.  Hematogenous spread of malignant melanoma cells in different stages of disease. , 1993, The Journal of investigative dermatology.

[11]  S. Faiss,et al.  [Fine needle aspiration cytology of metastatic malignant melanoma. Improvement of results with ultrasound control]. , 1993, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[12]  G. Schütz,et al.  Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Pittman,et al.  Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction , 1991, The Lancet.

[14]  T. Binder,et al.  [The value of fine-needle aspiration cytology in the after-care of malignant melanoma]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[15]  L. Layfield,et al.  Fine needle aspirate smear morphology in metastatic melanoma. , 1989, Acta cytologica.

[16]  B. Fornage,et al.  Sonographic detection and fine‐needle aspiration biopsy of nonpalpable recurrent or metastatic melanoma in subcutaneous tissues. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[17]  G. Schütz,et al.  Functional analysis of alternatively spliced tyrosinase gene transcripts. , 1988, The EMBO journal.

[18]  W. Johnston,et al.  Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. , 1986, Journal of the National Cancer Institute.